EarningsQ2 2025 Earnings Report

Outlook Therapeutics (41O) Q2 2025 Earnings Report

8 Followers

DE:41O Q2 2025 EPS Results

Actual EPS-€0.34

Consensus EPS-€0.47

Beat/MissBeat by +€0.12

One Year Ago EPS-€1.34

Actual Revenue€0.00

Expected Revenue€541.21K

Beat/MissMissed by -€541.21K

YoY Revenue Growth―

QuarterQ2 2025

Date05/15/2025

TimeAfter Close

Conference CallThursday, May 15, 2025

DE:41O Upcoming Earnings

Outlook Therapeutics's next earnings date is estimated for December 18, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Dec 18, 2026	2026 (Q4)	-0.06 / -	-0.052	―
Aug 14, 2026	2026 (Q3)	-0.07 / -0.08	-0.379	79.55% (+0.30)
May 15, 2026	2026 (Q2)	-0.10 / -0.14	-0.345	60.00% (+0.21)
Feb 17, 2026	2026 (Q1)	-0.20 / -0.19	-0.767	75.28% (+0.58)
Dec 19, 2025	2025 (Q4)	-0.22 / -0.05	-0.758	93.18% (+0.71)
Aug 14, 2025	2025 (Q3)	-0.30 / -0.38	-0.715	46.99% (+0.34)
May 15, 2025	2025 (Q2)	-0.47 / -0.34	-1.336	74.19% (+0.99)
Feb 14, 2025	2025 (Q1)	-0.65 / -0.77	-0.689	-11.25% (-0.08)
Dec 27, 2024	2024 (Q4)	-0.69 / -0.76	-0.862	12.00% (+0.10)
Aug 14, 2024	2024 (Q3)	-0.89 / -0.72	-1.379	48.13% (+0.66)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed